Chino, M.; Nakayama, H.; Nagai, H.; Terada, H.; Katata, G.; Yamazawa, H. Preliminary estimation of release amounts of 131 I and 137 Cs accidentally discharged from the Fukushima Daiichi nuclear power plant into the atmosphere. J. Nucl. Sci. Technol., 2011, 48(7), 1129-1134.
[http://dx.doi.org/10.1080/18811248.2011.9711799]

Yamashita, S.; Takamura, N.; Ohtsuru, A.; Suzuki, S. Radiation exposure and thyroid cancer risk after the fukushima nuclear power plant accident in comparison with the chernobyl accident. Radiat. Prot. Dosimetry, 2016, 171(1), 41-46.
[http://dx.doi.org/10.1093/rpd/ncw189] [PMID: 27473699]

U.S. Department of Health and Human Services. Agency for Toxic Substances and Disease Registry. Case studies in environmental medicine: Radiation Exposure from Iodine 131. 2002. Available from: https://www.atsdr.cdc.gov/hec/csem/iodine/docs/iodine131.pdf

Drozdovitch, V. Radiation exposure to the thyroid after the chernobyl accident. Front. Endocrinol., 2021, 11, 569041.
[http://dx.doi.org/10.3389/fendo.2020.569041] [PMID: 33469445]

Yamashita, S.; Suzuki, S. Risk of thyroid cancer after the fukushima nuclear power plant accident. Respir. Investig., 2013, 51(3), 128-133.
[http://dx.doi.org/10.1016/j.resinv.2013.05.007] [PMID: 23978638]

Shinkarev, S.M. Comparison of thyroid doses to the public from radioiodine following the chernobyl and fukushima accidents. Ann. ICRP, 2021, 50(S1), 174-180.
[http://dx.doi.org/10.1177/01466453211006816] [PMID: 34109835]

Sase, E.; Eddy, C.; Polivka, B.J. Lessons from fukushima: Potassium iodide after a nuclear disaster. Am. J. Nurs., 2021, 121(2), 63-67.
[http://dx.doi.org/10.1097/01.NAJ.0000734144.20889.b0] [PMID: 33497131]

Burchert, W.; Fehringer, F.; Kirchinger, W.; Kopp, J.; Port, M.; Reiners, C. Use of iodine tablets for thyroid blocking in the event of a nuclear emergency with release of radioactive iodine; German Commission On Radiological Protection - Bonn; Germany: Strahlenschutzkommission, 2019.

World Health Organization. Iodine thyroid blocking - Guidelines for use in planning for and responding to radiological and nuclear emergencies; World Health Organization: Geneva, Switzerland, 2017.

Verger, P.; Aurengo, A.; Geoffroy, B.; Le Guen, B. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: A review. Thyroid, 2001, 11(4), 353-360.
[http://dx.doi.org/10.1089/10507250152039082] [PMID: 11349833]

Reiners, C.; Schneider, R. Potassium Iodide (KI) to block the thyroid from exposure to I-131: Current questions and answers to be discussed. Radiat. Environ. Biophys., 2013, 52(2), 189-193.
[http://dx.doi.org/10.1007/s00411-013-0462-0] [PMID: 23475155]

Agopiantz, M.; Elhanbali, O.; Demore, B.; Cuny, T.; Demarquet, L.; Ndiaye, C.; Barbe, F.; Brunaud, L.; Weryha, G.; Klein, M. Thyroid side effects prophylaxis in front of nuclear power plant accidents. Ann. Endocrinol., 2016, 77(1), 1-6.
[http://dx.doi.org/10.1016/j.ando.2015.12.003] [PMID: 26830953]

Yamashita, S.; Suzuki, S.; Suzuki, S.; Shimura, H.; Saenko, V. Lessons from fukushima: Latest findings of thyroid cancer after the fuku-shima nuclear power plant accident. Thyroid, 2018, 28(1), 11-22.
[http://dx.doi.org/10.1089/thy.2017.0283] [PMID: 28954584]

Zanzonico, P.B.; Becker, D.V. Effects of time of administration and dietary iodine levels on Potassium Iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys., 2000, 78(6), 660-667.
[http://dx.doi.org/10.1097/00004032-200006000-00008] [PMID: 10832925]

Adalja, A.A. Use of Potassium Iodide (KI) in a nuclear emergency. Biosecur. Bioterror., 2011, 9(4), 405-407.
[http://dx.doi.org/10.1089/bsp.2011.1026] [PMID: 22077703]

Burki, T. War in Ukraine ups demand for iodine pills. Lancet Diabetes Endocrinol., 2022, 10(6), 388.
[http://dx.doi.org/10.1016/S2213-8587(22)00112-7] [PMID: 35395212]

Chiovato, L.; Magri, F.; Carlé, A. Hypothyroidism in context: Where we’ve been and where we’re going. Adv. Ther., 2019, 36(S2), 47-58.
[http://dx.doi.org/10.1007/s12325-019-01080-8] [PMID: 31485975]

Zimmermann, M.B.; Andersson, M. Global endocrinology: Global perspectives in endocrinology: Coverage of iodized salt programs and iodine status in 2020. Eur. J. Endocrinol., 2021, 185(1), R13-R21.
[http://dx.doi.org/10.1530/EJE-21-0171] [PMID: 33989173]

Bähre, M.; Hilgers, R.; Lindemann, C.; Emrich, D. Physiological aspects of the thyroid trapping function and its suppression in iodine deficiency using 99m Tc pertechnetate. Eur. J. Endocrinol., 1987, 115(2), 175-182.
[http://dx.doi.org/10.1530/acta.0.1150175] [PMID: 3037834]

Ratnos, C.D.; Zantut, W.D.E.; Tambascia, M.A.; Assumpção, L.; Etchebehere, E.C.S.C.; Camargo, E.E. Thyroid suppression test with L-thyroxine and [99m Tc] pertechnetate. Clin. Endocrinol., 2000, 52(4), 471-477.
[http://dx.doi.org/10.1046/j.1365-2265.2000.00898.x] [PMID: 10762290]

Reinhardt, M.J.; Högerle, S.; Trupkovic, T.; Krause, T.M.; Moser, E. Influence of urinary iodine excretion on thyroid technetium-99m pertechnetate uptake with and without TSH suppression: What happens when iodine supply increases? Eur. J. Nucl. Med., 1998, 25(11), 1475-1481.
[http://dx.doi.org/10.1007/s002590050324] [PMID: 9799342]

Phillppou, G.; Koutras, D.A.; Plperlngos, G.; Souvatzoglou, A.; Moulopoulos, S.D. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin. Endocrinol., 1992, 36(6), 573-578.
[http://dx.doi.org/10.1111/j.1365-2265.1992.tb02267.x] [PMID: 1424182]

Giovanella, L.; Avram, A.M.; Iakovou, I.; Kwak, J.; Lawson, S.A.; Lulaj, E.; Luster, M.; Piccardo, A.; Schmidt, M.; Tulchinsky, M.; Verburg, F.A.; Wolin, E. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur. J. Nucl. Med. Mol. Imaging, 2019, 46(12), 2514-2525.
[http://dx.doi.org/10.1007/s00259-019-04472-8] [PMID: 31392371]